Category: Gastroenterology/Hepatology

Acute Exacerbation of Chronic Hepatitis B: Volume 2. Diagnosis and Management

This book assembles recent achievements in both basic research and clinical management in the field of hepatology, virology and immunology. It provides up-to-date information for clinicians who can apply the relevant knowledge to their daily clinical practice and for researchers who are interested in clinically orientated studies. The updated and detailed technology, state-of–the-art treatment strategies provided in this book serve as references for clinicians and resident physicians in the daily management of ACLF. The rationality and strategies for basic research as well as patient management in this book can also be a valuable reference for other fatal and end stage liver diseases than HBV induced ACLF.

This Volume 2 has 6 chapters and focuses on its diagnosis and management.

DOWNLOAD THIS MEDICAL BOOK HERE

CURRENT Diagnosis & Treatment Gastroenterology, Hepatology, & Endoscopy

“I found this book contemporary and well written, with knowledgeable authorship and recommend it for a handy reference for students, primary care providers and in a busy practice, but not for detailed evaluations. It certainly is worthwhile spending the $69.95 to have it as a handy reference on the shelf of practitioners.”–Journal of Clinical Gastroenterology

Authored by expert physicians at Harvard Medical School and Brigham and Women’s Hospital, CURRENT Diagnosis & Treatment: Gastroenterology, Hepatology, & Endoscopy offers a streamlined, templated presentation that simplifies the diagnosis and medical management of digestive and liver diseases.

Clinically relevant, up-to-date coverage of digestive and liver disorders, and related medical and surgical procedures, including endoscopy:

• High-yield coverage of the entire spectrum of gastroenterology and hepatology, from stomach and esophageal to pancreatic and liver disorders
• Complete review of advances in diagnostic and therapeutic endoscopy
• “Essentials of Diagnosis” bulleted lists deliver instant guidance on identifying both common and rare digestive disorders
• Over 90 full-color endoscopic and other images of GI disorders
• Over 50 radiographic images clarify the use of the many currently available imaging techniques
• Key information from related fields, including GI surgery, and subspecialities such as liver transplantation, bariatric surgery, inflammatory bowel disease, and motility disorder

DOWNLOAD THIS MEDICAL BOOK HERE

Biomarkers in Inflammatory Bowel Diseases 1st ed

This book provides a comprehensive and complete overview of biomarkers in clinical practice for inflammatory bowel disease (IBD) bringing together the literature in a clear and concise manner. The book bridges the gap between growing knowledge at the bench and current and future applications of biomarkers in clinical practice.

The central structure of the book focuses on prognostic and predictive biomarkers in IBD with an emphasis on the fields of research and scientific techniques (genomics, proteomics and metabonomics) that have led to biomarker discovery and places these biomarkers within a clinical context to help understand their utility in clinical practice.

This book will be of use to clinicians who have an interest in using biomarkers in clinical practice as well as clinician researchers and scientists involved in the biomarker research pipeline.

The author team comprises experts from around the world in order to bring together the literature in an effort to inform clinicians and researchers about the current state-of-the art in biomarker discovery.  It is intended to  assist future research efforts and indicate how biomarkers might be best applied to clinical practice both at present and in the future.

DOWNLOAD THIS MEDICAL BOOK

HIV and GI Tract Complications: A Comprehensive Clinical Guide

DOWNLOAD THIS MEDICAL BOOK

[amazon_link asins=’B0075L1XYE’ template=’ProductAd’ store=’aishabano-20′ marketplace=’US’ link_id=’b3c414f0-eaa5-405a-b1a1-a2f6480dded8′]

Textbook of Gastroenterology, 2 Volume Set 5th Edition

DOWNLOAD THIS MEDICAL BOOK HERE

https://upsto.re/CJqqcdV

Over the past twenty years, thousands of physicians have come to depend on Yamada’s Textbook of Gastroenterology. Its encyclopaedic discussion of the basic science underlying gastrointestinal and liver diseases as well as the many diagnostic and therapeutic modalities available to the patients who suffer from them was—and still is—beyond compare. This new edition provides the latest information on current and projected uses of major technologies in the field and a new section on diseases of the liver. Plus, it comes with a fully searchable CD ROM of the entire content.

[amazon_link asins=’161737363X’ template=’ProductAd’ store=’aishabano-20′ marketplace=’US’ link_id=’31b5b956-32a0-4b05-bef9-bfcc302a8854′]

Hepatitis B and D Protocols: Volume 2: Immunology, Model Systems, and Clinical Studies

DOWNLOAD THIS MEDICAL BOOK HERE

https://upsto.re/CJbtw24

Despite the availability of an effective vaccine, there are still 400 million people, worldwide who are chronically infected with hepatitis B virus (HBV). For them, the vaccine, as currently applied, has no value. Given the possible consequences of HBV infection, the number of those chronically infected with HBV presents an enormous public health challenge. For example, the major etiology of hepatocellular carcinoma (HCC) is chronic infection with HBV. Although fifth in cancer incidence, worldwide, HCC/liver cancer is the third leading cause of cancer death. The high mortality as- ciated with HCC arises because the disease is often detected late and is unresponsive to treatment. The number of deaths caused by PHCC is expected to rise over the next 20 years. Those chronically infected with HBV have a life risk of death to HCC of between 10 and 25%. Even the limited efficacy of drugs for the treatment of chronic HBV helps underscore the point that this disease is responsive to therapy. Drugs that target the polymerase (e. g. , hepsera and lamivudine) and interferon alpha represent two distinct strategies and show that both conventional antiviral and immunothe- peutic approaches can be used in management. However, the current inventory of therapeutics is inadequate. Interferon alpha is of limited value, only parenterally ava- able, and fraught with adverse reactions.